[NFS-01] Neuroscience Frontier Symposium 01

[NFS-01-1] The role of TDP-43 in the lipid dysregulation in CNS of ALS

Naohiro Egawa^1,2,3 (1.Department of Neurology, Kyoto University Graduate School of Medicine, Japan, 2.iPSC-Based Drug Discovery and Development Team, RIKEN BioResource Research Center, Japan, 3.Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan)

Profile: Dr. Egawa has been engaged in (reverse) translational research of neurological diseases (ALS, dementia with Lewy bodies, Alzheimer's disease and sleep-related diseases) using stem cell models, rodent models and clinical informatics.

7/2019 - : Instructor, Kyoto University Hospital
4/2018 - : Visiting Researcher, RIKEN
4/2018 - : Visiting Researcher, CiRA, Kyoto University
6/2016 - : Assistant Professor, Department of Neurology, Kyoto University Graduate School of Medicine
4/2015 - 5/2016: Research Fellow, Massachusetts General Hospital,
Harvard Medical School
4/2010 - 3/2015: Research Fellow, Center for iPS Cell Research and Application (CiRA),
Kyoto University
4/2006 - 3/2010: Ph.D. in Medicine, Kyoto University
3/2001: M.D. Kyoto University